Congo vs Lithuania: Previously treated cases tested for RR-/MDR-TB (%)
Congo
100.0%
in 2024
Lithuania
100.0%
in 2024
Congo rank
1st
Lithuania rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Congo
- Lithuania
How they compare
Congo currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 11 years both countries report, Lithuania has been ahead every year.
Congo ranks 1st and Lithuania ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 100.0% | 22.8% | Lithuania |
| 2020s | 69.8% | 100.0% | 30.2% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Lithuania?
- Congo, at 100.0% against 100.0% in Lithuania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Lithuania?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Lithuania?
- 11 years are reported by both, from 2013 to 2024.
- How do Congo and Lithuania rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Lithuania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.